There are intermittent supply issues as some manufacturers have recently discontinued these products and others are having supply difficulties. Supplies of both strengths are currently available but may be limited. Supply is likely to be intermittent for a number of months. Manufacturers of carvedilol have indicated they would be unable to meet demand if patients were switched to this product. Memo advises on use of alternative beta blockers.